Survivorship Care Planning in Improving Quality of Life in Survivors of Ovarian Cancer
NCT ID: NCT02082470
Last Updated: 2017-09-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
14 participants
INTERVENTIONAL
2014-04-11
2017-09-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. To assess the feasibility and acceptability of survivorship care planning (SCP) in ovarian cancer.
SECONDARY OBJECTIVES:
I. To develop the infrastructure and strategy for a larger comparative intervention study (National Cancer Institute \[NCI\] R01).
OUTLINE: Participants are assigned to 1 of 2 arms.
ARM I: Participants receive standard post-treatment care consisting of regular cancer surveillance visits with treating oncologists.
ARM II: Participants complete survivorship care planning in close collaboration with treating oncologists.
After completion of study treatment, participants are followed up at 2 months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm I (standard post-treatment)
Participants receive standard post-treatment care consisting of regular cancer surveillance visits with treating oncologists.
active surveillance
Undergo cancer surveillance
questionnaire administration
Ancillary studies
Arm II (survivorship care planning)
Participants complete survivorship care planning in close collaboration with treating oncologists.
follow-up care
Undergo survivorship care planning
questionnaire administration
Ancillary studies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
follow-up care
Undergo survivorship care planning
active surveillance
Undergo cancer surveillance
questionnaire administration
Ancillary studies
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to read or understand English
* All subjects must have the ability to understand and the willingness to sign a written informed consent
Exclusion Criteria
21 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
City of Hope Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Virginia Sun
Role: PRINCIPAL_INVESTIGATOR
City of Hope Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
City of Hope Medical Center
Duarte, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2014-00423
Identifier Type: REGISTRY
Identifier Source: secondary_id
14001
Identifier Type: OTHER
Identifier Source: secondary_id
14001
Identifier Type: -
Identifier Source: org_study_id